Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study)

• Guidelines advocate a patient-centered approach to the management of hyperglycemia. • Patient engagement is a responsibility of both clinicians and patients. • Vildagliptin regimens improve glycemic outcomes in real-world clinical practice. • Several patient engagement activities are determinants...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
1. Verfasser: Hermans, Michel (VerfasserIn)
Weitere Verfasser: Van Gaal, Luc (BerichterstatterIn), Rézette, Ingrid (BerichterstatterIn), Daci, Evis (BerichterstatterIn), MacDonald, Karen (BerichterstatterIn), Denhaerynck, Kris (BerichterstatterIn), Vancayzeele, Stefaan (BerichterstatterIn), De Meester, Lut (BerichterstatterIn), Clemens, Andreas (BerichterstatterIn), Yee, Brian (BerichterstatterIn), Abraham, Ivo (BerichterstatterIn)
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2016
Zugriff auf das übergeordnete Werk:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
Schlagworte:Dipeptidyl peptidase-4 inhibitor Effectiveness Diabetes mellitus Vildagliptin Type 2 diabetes mellitus Outcomes
Umfang:9